|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Science
291:2150-2155
(2001)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure of an extracellular gp130 cytokine receptor signaling complex.
|
|
D.Chow,
X.He,
A.L.Snow,
S.Rose-John,
K.C.Garcia.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The activation of gp130, a shared signal-transducing receptor for a family of
cytokines, is initiated by recognition of ligand followed by oligomerization
into a higher order signaling complex. Kaposi's sarcoma-associated herpesvirus
encodes a functional homolog of human interleukin-6 (IL-6) that activates human
gp130. In the 2.4 angstrom crystal structure of the extracellular signaling
assembly between viral IL-6 and human gp130, two complexes are cross-linked into
a tetramer through direct interactions between the immunoglobulin domain of
gp130 and site III of viral IL-6, which is necessary for receptor activation.
Unlike human IL-6 (which uses many hydrophilic residues), the viral cytokine
largely uses hydrophobic amino acids to contact gp130, which enhances the
complementarity of the viral IL-6-gp130 binding interfaces. The cross-reactivity
of gp130 is apparently due to a chemical plasticity evident in the amphipathic
gp130 cytokine-binding sites.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Fig. 1. Electron density in the site III interface of the
vIL-6-gp130 complex. Viral IL-6 is in yellow and the gp130 D1
domain is in red. At the center of the map is vIL-6 Trp144,
which is at the core of the site III interface. The -sheet
strands of the gp130 D1 (F and G strands) are labeled in red.
The electron density map is a SIGMAA-weighted 2F[obs] - F[calc]
map at 2.4 Å contoured at 1.2 and
displayed with the program O (45).
|
 |
Figure 3.
Fig. 3. Molecular anatomy and shape complementarity of the site
II interface. (A) Amino acid contact residues within the site II
interface; gp130 (blue) is at the left and vIL-6 (purple) at the
right, and hydrogen bonds appear as red dotted lines. The
conserved gp130 Phe^169 and vIL-6 Trp18 are in the center of the
interface. (B and C) The site II vIL-6-gp130 interface is peeled
open, and the contact residues of one molecule are projected
onto the buried surface (red) of the interacting protein. Trp18
of vIL-6 (green) and Phe^169 of gp130 (blue) are used as anchor
points (arrows) to orient the reader between the two surfaces.
In (B), the gp130 contact residues (yellow) and binding-site
loops (blue) are shown as sticks projected onto the molecular
surface of vIL-6, where the buried portion is highlighted in
red. A deep canyon that receives the protruding gp130 elbow is
evident on the surface of vIL-6. The central Trp18 of vIL-6 is
highlighted on the red surface as a green patch. In (C), the
vIL-6 contact residues (yellow) and helices (pink) are drawn as
sticks projected onto the protruding molecular surface of gp130.
The Phe^169 of gp130 is drawn as a blue patch [see (38)].
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the AAAs:
Science
(2001,
291,
2150-2155)
copyright 2001.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
I.Lorenzen,
W.Shang,
M.Perbandt,
M.V.Petoukhov,
D.I.Svergun,
G.H.Waetzig,
S.Rose-John,
R.Hilgenfeld,
and
J.Grötzinger
(2011).
The structure of the unliganded extracellular domain of the interleukin-6 signal transducer gp130 in solution.
|
| |
Eur J Cell Biol,
90,
515-520.
|
 |
|
|
|
|
 |
J.Scheller,
A.Chalaris,
D.Schmidt-Arras,
and
S.Rose-John
(2011).
The pro- and anti-inflammatory properties of the cytokine interleukin-6.
|
| |
Biochim Biophys Acta,
1813,
878-888.
|
 |
|
|
|
|
 |
J.Suthaus,
N.Adam,
J.Grötzinger,
J.Scheller,
and
S.Rose-John
(2011).
Viral Interleukin-6: Structure, pathophysiology and strategies of neutralization.
|
| |
Eur J Cell Biol,
90,
495-504.
|
 |
|
|
|
|
 |
M.N.Kostjukova,
and
N.N.Tupitsyn
(2011).
Functional Properties of Extracellular Domains of Transducer Receptor gp130.
|
| |
Biochemistry (Mosc),
76,
394-406.
|
 |
|
|
|
|
 |
C.J.Hong,
P.J.Tsai,
C.Y.Cheng,
C.K.Chou,
H.F.Jheng,
Y.C.Chuang,
C.N.Yang,
Y.T.Lin,
C.W.Hsu,
I.H.Cheng,
S.Y.Chen,
S.J.Tsai,
Y.J.Liou,
and
Y.S.Tsai
(2010).
ENU mutagenesis identifies mice with morbid obesity and severe hyperinsulinemia caused by a novel mutation in leptin.
|
| |
PLoS One,
5,
e15333.
|
 |
|
|
|
|
 |
G.H.Waetzig,
A.Chalaris,
P.Rosenstiel,
J.Suthaus,
C.Holland,
N.Karl,
L.Vallés Uriarte,
A.Till,
J.Scheller,
J.Grötzinger,
S.Schreiber,
S.Rose-John,
and
D.Seegert
(2010).
N-linked glycosylation is essential for the stability but not the signaling function of the interleukin-6 signal transducer glycoprotein 130.
|
| |
J Biol Chem,
285,
1781-1789.
|
 |
|
|
|
|
 |
M.Robinson,
S.R.Gray,
M.S.Watson,
G.Kennedy,
A.Hill,
J.J.Belch,
and
M.A.Nimmo
(2010).
Plasma IL-6, its soluble receptors and F2-isoprostanes at rest and during exercise in chronic fatigue syndrome.
|
| |
Scand J Med Sci Sports,
20,
282-290.
|
 |
|
|
|
|
 |
S.Mirza,
A.Walker,
J.Chen,
J.M.Murphy,
and
I.G.Young
(2010).
The Ig-like domain of human GM-CSF receptor alpha plays a critical role in cytokine binding and receptor activation.
|
| |
Biochem J,
426,
307-317.
|
 |
|
|
|
|
 |
C.S.Dela Cruz,
S.R.Viswanathan,
A.S.El-Guindy,
D.Shedd,
and
G.Miller
(2009).
Complex N-linked glycans on Asn-89 of Kaposi sarcoma herpes virus-encoded interleukin-6 mediate optimal function by affecting cytokine protein conformation.
|
| |
J Biol Chem,
284,
29269-29282.
|
 |
|
|
|
|
 |
D.Chen,
G.Sandford,
and
J.Nicholas
(2009).
Intracellular signaling mechanisms and activities of human herpesvirus 8 interleukin-6.
|
| |
J Virol,
83,
722-733.
|
 |
|
|
|
|
 |
D.Chen,
Y.B.Choi,
G.Sandford,
and
J.Nicholas
(2009).
Determinants of secretion and intracellular localization of human herpesvirus 8 interleukin-6.
|
| |
J Virol,
83,
6874-6882.
|
 |
|
|
|
|
 |
J.M.Dias,
C.Losberger,
M.Déruaz,
C.A.Power,
A.E.Proudfoot,
and
J.P.Shaw
(2009).
Structural basis of chemokine sequestration by a tick chemokine binding protein: the crystal structure of the complex between Evasin-1 and CCL3.
|
| |
PLoS One,
4,
e8514.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
N.Adam,
B.Rabe,
J.Suthaus,
J.Grötzinger,
S.Rose-John,
and
J.Scheller
(2009).
Unraveling viral interleukin-6 binding to gp130 and activation of STAT-signaling pathways independently of the interleukin-6 receptor.
|
| |
J Virol,
83,
5117-5126.
|
 |
|
|
|
|
 |
S.Rebouissou,
M.Amessou,
G.Couchy,
K.Poussin,
S.Imbeaud,
C.Pilati,
T.Izard,
C.Balabaud,
P.Bioulac-Sage,
and
J.Zucman-Rossi
(2009).
Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours.
|
| |
Nature,
457,
200-204.
|
 |
|
|
|
|
 |
X.Wang,
P.Lupardus,
S.L.Laporte,
and
K.C.Garcia
(2009).
Structural biology of shared cytokine receptors.
|
| |
Annu Rev Immunol,
27,
29-60.
|
 |
|
|
|
|
 |
C.Wu,
S.L.Lo,
J.Boulaire,
M.L.Hong,
H.M.Beh,
D.S.Leung,
and
S.Wang
(2008).
A peptide-based carrier for intracellular delivery of proteins into malignant glial cells in vitro.
|
| |
J Control Release,
130,
140-145.
|
 |
|
|
|
|
 |
E.Sudarman,
M.Bollati-Fogolín,
M.Hafner,
W.Müller,
J.Scheller,
S.Rose-John,
and
J.Eichler
(2008).
Synthetic mimetics of the gp130 binding site for viral interleukin-6 as inhibitors of the vIL-6-gp130 interaction.
|
| |
Chem Biol Drug Des,
71,
494-500.
|
 |
|
|
|
|
 |
F.Carafoli,
J.L.Saffell,
and
E.Hohenester
(2008).
Structure of the tandem fibronectin type 3 domains of neural cell adhesion molecule.
|
| |
J Mol Biol,
377,
524-534.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
F.Rousseau,
S.Chevalier,
C.Guillet,
E.Ravon,
C.Diveu,
J.Froger,
F.Barbier,
L.Grimaud,
and
H.Gascan
(2008).
Ciliary neurotrophic factor, cardiotrophin-like cytokine, and neuropoietin share a conserved binding site on the ciliary neurotrophic factor receptor alpha chain.
|
| |
J Biol Chem,
283,
30341-30350.
|
 |
|
|
|
|
 |
G.Skiniotis,
P.J.Lupardus,
M.Martick,
T.Walz,
and
K.C.Garcia
(2008).
Structural organization of a full-length gp130/LIF-R cytokine receptor transmembrane complex.
|
| |
Mol Cell,
31,
737-748.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.A.Denessiouk,
A.I.Denesyuk,
and
M.S.Johnson
(2008).
Negative modulation of signal transduction via interleukin splice variation.
|
| |
Proteins,
71,
751-770.
|
 |
|
|
|
|
 |
M.Cardó-Vila,
A.J.Zurita,
R.J.Giordano,
J.Sun,
R.Rangel,
L.Guzman-Rojas,
C.D.Anobom,
A.P.Valente,
F.C.Almeida,
J.Lahdenranta,
M.G.Kolonin,
W.Arap,
and
R.Pasqualini
(2008).
A ligand peptide motif selected from a cancer patient is a receptor-interacting site within human interleukin-11.
|
| |
PLoS ONE,
3,
e3452.
|
 |
|
|
|
|
 |
P.Gasperini,
S.Sakakibara,
and
G.Tosato
(2008).
Contribution of viral and cellular cytokines to Kaposi's sarcoma-associated herpesvirus pathogenesis.
|
| |
J Leukoc Biol,
84,
994.
|
 |
|
|
|
|
 |
P.J.Lupardus,
and
K.C.Garcia
(2008).
The structure of interleukin-23 reveals the molecular basis of p40 subunit sharing with interleukin-12.
|
| |
J Mol Biol,
382,
931-941.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.R.Gray,
M.Robinson,
and
M.A.Nimmo
(2008).
Response of plasma IL-6 and its soluble receptors during submaximal exercise to fatigue in sedentary middle-aged men.
|
| |
Cell Stress Chaperones,
13,
247-251.
|
 |
|
|
|
|
 |
W.Liu,
M.Kawahara,
H.Ueda,
and
T.Nagamune
(2008).
Construction of a fluorescein-responsive chimeric receptor with strict ligand dependency.
|
| |
Biotechnol Bioeng,
101,
975-984.
|
 |
|
|
|
|
 |
R.Matadeen,
W.C.Hon,
J.K.Heath,
E.Y.Jones,
and
S.Fuller
(2007).
The dynamics of signal triggering in a gp130-receptor complex.
|
| |
Structure,
15,
441-448.
|
 |
|
|
|
|
 |
T.Wehrman,
X.He,
B.Raab,
A.Dukipatti,
H.Blau,
and
K.C.Garcia
(2007).
Structural and mechanistic insights into nerve growth factor interactions with the TrkA and p75 receptors.
|
| |
Neuron,
53,
25-38.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
W.Greene,
K.Kuhne,
F.Ye,
J.Chen,
F.Zhou,
X.Lei,
and
S.J.Gao
(2007).
Molecular biology of KSHV in relation to AIDS-associated oncogenesis.
|
| |
Cancer Treat Res,
133,
69.
|
 |
|
|
|
|
 |
A.Gertler
(2006).
Development of leptin antagonists and their potential use in experimental biology and medicine.
|
| |
Trends Endocrinol Metab,
17,
372-378.
|
 |
|
|
|
|
 |
D.Chen,
and
J.Nicholas
(2006).
Structural requirements for gp80 independence of human herpesvirus 8 interleukin-6 (vIL-6) and evidence for gp80 stabilization of gp130 signaling complexes induced by vIL-6.
|
| |
J Virol,
80,
9811-9821.
|
 |
|
|
|
|
 |
J.Scheller,
and
S.Rose-John
(2006).
Interleukin-6 and its receptor: from bench to bedside.
|
| |
Med Microbiol Immunol,
195,
173-183.
|
 |
|
|
|
|
 |
M.Kovaleva,
I.Bussmeyer,
B.Rabe,
J.Grötzinger,
E.Sudarman,
J.Eichler,
U.Conrad,
S.Rose-John,
and
J.Scheller
(2006).
Abrogation of viral interleukin-6 (vIL-6)-induced signaling by intracellular retention and neutralization of vIL-6 with an anti-vIL-6 single-chain antibody selected by phage display.
|
| |
J Virol,
80,
8510-8520.
|
 |
|
|
|
|
 |
T.Tamada,
E.Honjo,
Y.Maeda,
T.Okamoto,
M.Ishibashi,
M.Tokunaga,
and
R.Kuroki
(2006).
Homodimeric cross-over structure of the human granulocyte colony-stimulating factor (GCSF) receptor signaling complex.
|
| |
Proc Natl Acad Sci U S A,
103,
3135-3140.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.A.Anderson,
C.E.Kendal,
M.Garcia-Maya,
A.V.Kenny,
S.A.Morris-Triggs,
T.Wu,
R.Reynolds,
E.Hohenester,
and
J.L.Saffell
(2005).
A peptide from the first fibronectin domain of NCAM acts as an inverse agonist and stimulates FGF receptor activation, neurite outgrowth and survival.
|
| |
J Neurochem,
95,
570-583.
|
 |
|
|
|
|
 |
A.Doganci,
T.Eigenbrod,
N.Krug,
G.T.De Sanctis,
M.Hausding,
V.J.Erpenbeck,
e.l.-.B.Haddad,
H.A.Lehr,
E.Schmitt,
T.Bopp,
K.J.Kallen,
U.Herz,
S.Schmitt,
C.Luft,
O.Hecht,
J.M.Hohlfeld,
H.Ito,
N.Nishimoto,
K.Yoshizaki,
T.Kishimoto,
S.Rose-John,
H.Renz,
M.F.Neurath,
P.R.Galle,
and
S.Finotto
(2005).
The IL-6R alpha chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo.
|
| |
J Clin Invest,
115,
313-325.
|
 |
|
|
|
|
 |
A.Schroers,
O.Hecht,
K.J.Kallen,
M.Pachta,
S.Rose-John,
and
J.Grötzinger
(2005).
Dynamics of the gp130 cytokine complex: a model for assembly on the cellular membrane.
|
| |
Protein Sci,
14,
783-790.
|
 |
|
|
|
|
 |
D.Perret,
F.Rousseau,
V.Tran,
and
H.Gascan
(2005).
Reversal of some viral IL-6 electrostatic properties compared to IL-6 contributes to a loss of alpha receptor component recruitment.
|
| |
Proteins,
60,
14-26.
|
 |
|
|
|
|
 |
E.Honjo,
T.Tamada,
Y.Maeda,
T.Koshiba,
Y.Matsukura,
T.Okamoto,
M.Ishibashi,
M.Tokunaga,
and
R.Kuroki
(2005).
Crystallization of a 2:2 complex of granulocyte-colony stimulating factor (GCSF) with the ligand-binding region of the GCSF receptor.
|
| |
Acta Crystallogr Sect F Struct Biol Cryst Commun,
61,
788-790.
|
 |
|
|
|
|
 |
G.Skiniotis,
M.J.Boulanger,
K.C.Garcia,
and
T.Walz
(2005).
Signaling conformations of the tall cytokine receptor gp130 when in complex with IL-6 and IL-6 receptor.
|
| |
Nat Struct Mol Biol,
12,
545-551.
|
 |
|
|
|
|
 |
J.Nicholas
(2005).
Human gammaherpesvirus cytokines and chemokine receptors.
|
| |
J Interferon Cytokine Res,
25,
373-383.
|
 |
|
|
|
|
 |
S.Pletnev,
E.Magracheva,
A.Wlodawer,
and
A.Zdanov
(2005).
A model of the ternary complex of interleukin-10 with its soluble receptors.
|
| |
BMC Struct Biol,
5,
10.
|
 |
|
|
|
|
 |
C.S.Dela Cruz,
Y.Lee,
S.R.Viswanathan,
A.S.El-Guindy,
J.Gerlach,
S.Nikiforow,
D.Shedd,
L.Gradoville,
and
G.Miller
(2004).
N-linked glycosylation is required for optimal function of Kaposi's sarcoma herpesvirus-encoded, but not cellular, interleukin 6.
|
| |
J Exp Med,
199,
503-514.
|
 |
|
|
|
|
 |
S.Krause,
D.Würdemann,
A.Wentzel,
A.Christmann,
H.Fehr,
H.Kolmar,
and
K.Friedrich
(2004).
Bacteria displaying interleukin-4 mutants stimulate mammalian cells and reflect the biological activities of variant soluble cytokines.
|
| |
Chembiochem,
5,
804-810.
|
 |
|
|
|
|
 |
H.Ishikawa,
N.Tsuyama,
and
M.M.Kawano
(2003).
Interleukin-6-induced proliferation of human myeloma cells associated with CD45 molecules.
|
| |
Int J Hematol,
78,
95.
|
 |
|
|
|
|
 |
J.Nicholas
(2003).
Human herpesvirus-8-encoded signalling ligands and receptors.
|
| |
J Biomed Sci,
10,
475-489.
|
 |
|
|
|
|
 |
L.A.Dourmishev,
A.L.Dourmishev,
D.Palmeri,
R.A.Schwartz,
and
D.M.Lukac
(2003).
Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis.
|
| |
Microbiol Mol Biol Rev,
67,
175.
|
 |
|
|
|
|
 |
M.J.Boulanger,
A.J.Bankovich,
T.Kortemme,
D.Baker,
and
K.C.Garcia
(2003).
Convergent mechanisms for recognition of divergent cytokines by the shared signaling receptor gp130.
|
| |
Mol Cell,
12,
577-589.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
O.D.Liang,
T.Chavakis,
M.Linder,
K.Bdeir,
A.Kuo,
and
K.T.Preissner
(2003).
Binding of urokinase plasminogen activator to gp130 via a putative urokinase-binding consensus sequence.
|
| |
Biol Chem,
384,
229-236.
|
 |
|
|
|
|
 |
P.S.Moore,
and
Y.Chang
(2003).
Kaposi's sarcoma-associated herpesvirus immunoevasion and tumorigenesis: two sides of the same coin?
|
| |
Annu Rev Microbiol,
57,
609-639.
|
 |
|
|
|
|
 |
T.M.Rose,
J.T.Ryan,
E.R.Schultz,
B.W.Raden,
and
C.C.Tsai
(2003).
Analysis of 4.3 kilobases of divergent locus B of macaque retroperitoneal fibromatosis-associated herpesvirus reveals a close similarity in gene sequence and genome organization to Kaposi's sarcoma-associated herpesvirus.
|
| |
J Virol,
77,
5084-5097.
|
 |
|
|
|
|
 |
A.Timmermann,
A.Küster,
I.Kurth,
P.C.Heinrich,
and
G.Müller-Newen
(2002).
A functional role of the membrane-proximal extracellular domains of the signal transducer gp130 in heterodimerization with the leukemia inhibitory factor receptor.
|
| |
Eur J Biochem,
269,
2716-2726.
|
 |
|
|
|
|
 |
C.Guillet,
E.Lelièvre,
H.Plun-Favreau,
J.Froger,
M.Chabbert,
J.Hermann,
A.Benoit de Coignac,
J.Y.Bonnefoy,
H.Gascan,
J.F.Gauchat,
and
G.Elson
(2002).
Functionally active fusion protein of the novel composite cytokine CLC/soluble CNTF receptor.
|
| |
Eur J Biochem,
269,
1932-1941.
|
 |
|
|
|
|
 |
H.Deng,
M.J.Song,
J.T.Chu,
and
R.Sun
(2002).
Transcriptional regulation of the interleukin-6 gene of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus).
|
| |
J Virol,
76,
8252-8264.
|
 |
|
|
|
|
 |
H.Li,
and
J.Nicholas
(2002).
Identification of amino acid residues of gp130 signal transducer and gp80 alpha receptor subunit that are involved in ligand binding and signaling by human herpesvirus 8-encoded interleukin-6.
|
| |
J Virol,
76,
5627-5636.
|
 |
|
|
|
|
 |
J.N.Varghese,
R.L.Moritz,
M.Z.Lou,
A.Van Donkelaar,
H.Ji,
N.Ivancic,
K.M.Branson,
N.E.Hall,
and
R.J.Simpson
(2002).
Structure of the extracellular domains of the human interleukin-6 receptor alpha -chain.
|
| |
Proc Natl Acad Sci U S A,
99,
15959-15964.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.Song,
T.Ohkura,
M.Sugimoto,
Y.Mori,
R.Inagi,
K.Yamanishi,
K.Yoshizaki,
and
N.Nishimoto
(2002).
Human interleukin-6 induces human herpesvirus-8 replication in a body cavity-based lymphoma cell line.
|
| |
J Med Virol,
68,
404-411.
|
 |
|
|
|
|
 |
M.Klouche,
N.Brockmeyer,
C.Knabbe,
and
S.Rose-John
(2002).
Human herpesvirus 8-derived viral IL-6 induces PTX3 expression in Kaposi's sarcoma cells.
|
| |
AIDS,
16,
F9-18.
|
 |
|
|
|
|
 |
O.Martínez-Maza,
and
E.C.Breen
(2002).
B-cell activation and lymphoma in patients with HIV.
|
| |
Curr Opin Oncol,
14,
528-532.
|
 |
|
|
|
|
 |
R.G.Jenner,
and
C.Boshoff
(2002).
The molecular pathology of Kaposi's sarcoma-associated herpesvirus.
|
| |
Biochim Biophys Acta,
1602,
1.
|
 |
|
|
|
|
 |
S.Viswanathan,
T.Benatar,
S.Rose-John,
D.A.Lauffenburger,
and
P.W.Zandstra
(2002).
Ligand/receptor signaling threshold (LIST) model accounts for gp130-mediated embryonic stem cell self-renewal responses to LIF and HIL-6.
|
| |
Stem Cells,
20,
119-138.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |